Chonnam Med J.  2017 Jan;53(1):69-72. 10.4068/cmj.2017.53.1.69.

Supraclavicular Lymph Node Excision Biopsy in Patients with Suspected Supraclavicular Lymph Node Metastasis of Lung Cancer: Experience in a Tertiary Hospital

• Lee DH
• Yoon TM
• Lee JK
• Lim SC

• KMID: 2367342
• DOI: http://doi.org/10.4068/cmj.2017.53.1.69

Abstract

The aim of this study was to evaluate the usefulness and accuracy of supraclavicular lymph node excision biopsy in the diagnosis of suspected supraclavicular lymph node metastasis of lung cancer. A retrospective review was performed to evaluate patients with suspected supraclavicular lymph node metastasis of lung cancer who underwent supraclavicular lymph node excision biopsy from January 2011 to July 2014. Forty-six patients with suspected supraclavicular lymph node metastasis of lung cancer underwent supraclavicular lymph node excision biopsy, which diagnosed benign diseases in 6 patients and malignant diseases in 40 patients. Supraclavicular lymph node excision biopsy was usually performed on patients during their first clinical visit under local anesthesia. For diagnosing suspected lung cancer, supraclavicular lymph node excision biopsy had a diagnostic sensitivity of 100%, specificity of 97.6%, positive-predictive value of 83.3%, negative-predictive value of 100%, and accuracy of 97.8%. No major complication resulted from surgical intervention. Supraclavicular lymph node excision biopsy is a useful and accurate adjunct for the evaluation of suspected supraclavicular lymph node metastasis of lung cancer in a tertiary hospital.

Keyword

Neck; Lymph Node Excision; Lung Neoplasms; Lymphatic Metastasis

MeSH Terms

Anesthesia, Local
Biopsy
Diagnosis
Humans
Lung Neoplasms*
Lung*
Lymph Node Excision*
Lymph Nodes*
Lymphatic Metastasis
Neck
Neoplasm Metastasis*
Retrospective Studies
Sensitivity and Specificity
Tertiary Care Centers*

Reference

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000; 50:7–33.

2. Fultz PJ, Feins RH, Strang JG, Wandtke JC, Johnstone DW, Watson TJ, et al. Detection and diagnosis of nonpalpable supraclavicular lymph nodes in lung cancer at CT and US. Radiology. 2002; 222:245–251.

3. Kumaran M, Benamore RE, Vaidhyanath R, Muller S, Richards CJ, Peake MD, et al. Ultrasound guided cytological aspiration of supraclavicular lymph nodes in patients with suspected lung cancer. Thorax. 2005; 60:229–233.

4. Sung YM, Lee KS, Kim BT, Kim S, Kwon OJ, Choi JY, et al. Nonpalpable supraclavicular lymph nodes in lung cancer patients: preoperative characterization with 18F-FDG PET/CT. AJR Am J Roentgenol. 2008; 190:246–252.

5. van Overhagen H, Brakel K, Heijenbrok MW, van Kasteren JH, van de Moosdijk CN, Roldaan AC, et al. Metastases in supraclavicular lymph nodes in lung cancer: assessment with palpation, US, and CT. Radiology. 2004; 232:75–80.

6. Brantigan JW, Brantigan CO, Brantigan OC. Biopsy of nonpalpable scalene lymph nodes in carcinoma of the lung. Am Rev Respir Dis. 1973; 107:962–974.

7. Grondin SC, Liptay MJ. Current concepts in the staging of non-small cell lung cancer. Surg Oncol. 2002; 11:181–190.

8. Sihoe AD, Yim AP. Lung cancer staging. J Surg Res. 2004; 117:92–106.

9. LeBlanc JK, Espada R, Ergun G. Non-small cell lung cancer staging techniques and endoscopic ultrasound: tissue is still the issue. Chest. 2003; 123:1718–1725.

10. Miller WE, Taylor AM. Biopsy of scalene and supraclavicular lymph nodes: value in diagnosis. Cleve Clin Q. 1965; 32:205–209.

11. Bernstein MP, Ferrara JJ, Brown L. Effectiveness of scalene node biopsy for staging of lung cancer in the absence of palpable adenopathy. J Surg Oncol. 1985; 29:46–49.